Reducing infection rates after heart surgery with new dressings
Reducing Surgical Site Infection Rates Using an Alternative Sternal Dressing
NA · Stanford University · NCT03346694
This study is testing whether two new types of dressings can lower the risk of infections after heart surgery compared to a standard dressing.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 660 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Stanford University (other) |
| Locations | 1 site (Stanford, California) |
| Trial ID | NCT03346694 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of two alternative dressings compared to a standard dressing in reducing surgical site infection (SSI) rates among patients undergoing cardiac surgery with a sternotomy incision. Participants will be randomly assigned to one of three dressing types: Standard Island Dressing, Prevena Negative Pressure wound dressing, or Mepilex Border Post-Op Ag. The study will also assess the impact of these dressings on hospital readmission rates related to SSI within 30 days post-surgery.
Who should consider this trial
Good fit: Ideal candidates for this study are patients scheduled to undergo cardiac surgery involving a sternotomy incision.
Not a fit: Patients undergoing heart transplants or those with complicated postoperative courses will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could significantly reduce the rates of surgical site infections in cardiac surgery patients, leading to better patient outcomes and lower healthcare costs.
How similar studies have performed: Other studies have shown promising results with alternative dressing methods in reducing infection rates, suggesting that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants who will undergo cardiac surgery via a sternotomy incision.Inclusion criteria will be patients having surgical valve, CABGs, aortic dissection, myectomy and myotomy, Cox MAZE, Myocardial bridge Un-roofing Exclusion Criteria: * Patients undergoing heart transplants, Ventricular Assist Device (VAD), with postoperative courses complicated by tamponade, take-backs, and open chest incisions will also be excluded.
Where this trial is running
Stanford, California
- Stanford Healthcare — Stanford, California, United States (RECRUITING)
Study contacts
- Principal investigator: Jack Boyd, M.D. — Cardiovascular Surgeon
- Study coordinator: Jack Boyd, M.D.
- Email: jackboyd@stanford.edu
- Phone: 650-736-2042
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Wound of Skin